A study published in the Journal of Clinical Endocrinology and Metabolism  explores the relationship between weight loss, vitamin D status, | Cardiology ...

Dec. 3, 2024 — Using significantly higher doses of vitamin D than recommended for five years did not affect the incidence of type 2 diabetes in elderly men and women, according to a new ...

Low concentrations of 25-OH vitamin D causes secondary hyperparathyroidism (high levels of parathyroid hormone or PTH). This means a person loses more calcium from his/her bones when PTH is ...

the "normal" blood level of vitamin D (25-OH vitamin D) was based on the amount needed to keep PTH from becoming abnormally high. Again, PTH at high levels can cause calcium loss from the bone ...

Vitamin D (calciferol) and vitamin K2 (menaquinone) are essential nutrients supporting several aspects of health. Vitamin D is beneficial for bone and heart health and inflammation. Vitamin K2 is ...

Over the last few days, I have seen two patients who had serious complications because of a vitamin D overdose, which is toxic for the human body. It was a reminder how we treat supplements callously ...

Millions of postmenopausal women find themselves facing a diagnosis of osteoporosis, but what does that mean for their daily ...

FRAX is a tool to evaluate fracture risk based on individual patient models, incorporating clinical risk factors and bone ...

Nov. 6, 2024 — Children whose mothers took extra vitamin D during pregnancy continue to have stronger bones at age seven, according to ... Two Key Genes Identified Linking Rheumatoid Arthritis a ...

Taylor Leamey writes about all things wellness, specializing in mental health, sleep and nutrition coverage. She has invested hundreds of hours into studying and researching sleep and holds a ...

Taylor Leamey writes about all things wellness, specializing in mental health, sleep and nutrition coverage. She has invested hundreds of hours into studying and researching sleep and holds a ...

Orsini has been selected by Ascendis Pharma as a specialty pharmacy partner for YORVIPATH® (palopegteriparatide), an FDA-approved parathyroid hormone analog (PTH(1-34)) indicated for the treatment of ...